awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33604121-0D632C9D-F0DF-4954-973B-76CD4B411C59
Q33604121-0D632C9D-F0DF-4954-973B-76CD4B411C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33604121-0D632C9D-F0DF-4954-973B-76CD4B411C59
Immune-based therapeutics for pediatric cancer.
P2860
Q33604121-0D632C9D-F0DF-4954-973B-76CD4B411C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33604121-0D632C9D-F0DF-4954-973B-76CD4B411C59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef2d8d4a6d112129cf08f199801a82daeb4aea2e
P2860
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.